<DOC>
	<DOCNO>NCT00640705</DOCNO>
	<brief_summary>The primary purpose study assess effectiveness daily application diclofenac sodium patch skin near painful area . In study , location study either leave right ankle . The secondary purpose study assess safety tolerability diclofenac patch skin .</brief_summary>
	<brief_title>Diclofenac Patch Treatment Mild Moderate Ankle Sprain</brief_title>
	<detailed_description>Cerimon Pharmaceuticals investigate topical patch formulation diclofenac sodium contain 15 mg diclofenac sodium local treatment acute musculoskeletal pain .</detailed_description>
	<mesh_term>Ankle Injuries</mesh_term>
	<mesh_term>Sprains Strains</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>18 75 year age Has sustain painful Grade 1 2 ankle sprain ( Appendix H ) 48 hour prior study entry Presence pain least 5 , maximum 9 , 11point Numerical Rating Scale ( NRS ) Grade 3 ankle sprain bilateral sprain ( see Appendix H ) Previous injury ankle within 3 month prior current injury Aspirin short halflife NSAID use within 12 hour , long halflife NSAID use within 24 hour prior study entry ( Appendix B ) Opioid use within 24 hour prior study entry Topical treatment , ice pack , apply painful region since time injury A history peptic ulcer disease within 1 year study entry , history gastrointestinal bleeding coagulation disorder A history , evidence , underlie disease injured ankle , osteoarthritis gout Clinically significant , poorly control pulmonary , gastrointestinal , hepatic , renal , endocrine , cardiovascular disease A history hypersensitivity diclofenac diclofenaccontaining product A history intolerance acetaminophen ( rescue medication trial ) A history skin sensitivity adhesive ( e.g . adhesive tape ) Pregnant breastfeed woman woman childbearing potential use effective mean contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
</DOC>